Ethylenediamine

Ethylenediamine

SCHEMBL188360

Cl[Pt]Cl.NCCN

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADORA1ADORA2AADORA2BADORA3PDE3APDE3BPDE4APDE4BPDE4CPDE4D

The experimentally established mechanism targets of Ethylenediamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 457 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122032620-A Catalyst for generating tetrahydrofuran by furfural in one step, and preparation method and application thereof 河南省生物基材料产业研究院有限公司 2026-05-15 CN claimed
CN-119082815-A Platinum electroplating solution, preparation method thereof and application thereof in wafer electroplating 昆山一鼎工业科技有限公司 2024-12-06 CN claimed
CN-118668195-B Electroless platinating solution, preparation method thereof and application thereof in wafer electroless platinating 昆山一鼎工业科技有限公司 2024-11-26 CN claimed
CN-118162187-A Method for synthesizing molecular sieve encapsulated metal catalyst in situ by stabilizing bifunctional ligand 中国科学院大连化学物理研究所 2024-06-11 CN claimed
CN-114887648-B Preparation method of catalyst for synthesizing dimethyl oxalate and co-producing dimethyl carbonate by methyl nitrite carbonylation 中国石油大学(华东) 2023-08-04 CN claimed
EP-3693022-A2 COX-2-TARGETING, PLATINUM-CONTAINING CONJUGATES AND THEIR USE IN THE TREATMENT OF TUMORS AND CANCERS Reiley Pharmaceuticals, Inc. (US) 2020-08-12 EP claimed
US-20160200752-A1 COX-2-TARGETING, PLATINUM-CONTAINING CONJUGATES AND THEIR USE IN THE TREATMENT OF TUMORS AND CANCERS Reiley Pharmaceuticals, Inc. 2016-07-14 US claimed
US-9334440-B2 Processes for synthesizing nanocrystals and nanocrystal compositions SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-05-10 US claimed
EP-2870648-A1 METHOD OF PREPARING A CATALYTIC STRUCTURE Teknologisk Institut (DK) 2015-05-13 EP claimed
US-8945244-B2 Method and composition for improving fuel combustion CARROLL & ASSOCIATES LLC 2015-02-03 US claimed
US-6187817-B1 PREVENTING OR REDUCING OTOTOXICITY IN A HUMAN, CAT OR DOG BY ADMINISTERING D-METHIONINE FREE OF THE L-ISOMER SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE 2001-02-13 US claimed
WO-2000023096-A2 COMBINATION THERAPY WITH VIP ANTAGONIST THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2000-04-27 WO claimed
WO-1998039334-A9 DNA GLYCOSYLASE INHIBITORS, AND USES RELATED THERETO 1999-02-18 WO claimed
WO-1998039334-A1 DNA GLYCOSYLASE INHIBITORS, AND USES RELATED THERETO PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 1998-09-11 WO claimed
EP-0612248-A4 COMBINATION CHEMOTHERAPY. SMITHKLINE BEECHAM CORP (US) 1996-05-08 EP claimed
EP-0612248-A1 COMBINATION CHEMOTHERAPY SMITHKLINE BEECHAM CORPORATION (US) 1994-08-31 EP claimed
WO-1993009782-A1 COMBINATION CHEMOTHERAPY SMITHKLINE BEECHAM CORPORATION (US) 1993-05-27 WO claimed
EP-0241760-B1 CATALYST AND PROCESS FOR THE CATALYTIC HYDROGENATION OF FATTY ACID METHYL ESTERS IN A FIXED BED Henkel Kommanditgesellschaft auf Aktien (DE) 1990-12-19 EP claimed
US-4843161-A Platinum-intercalative complexes for the treatment of cancer MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 1989-06-27 US claimed
EP-0163316-A1 Platinum-intercalative complexes for the treatment of cancer MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 1985-12-04 EP claimed